HomeDIVISLAB • NSE
add
Divi's Laboratories Ltd
Nakaraang pagsara
₹5,771.35
Sakop ng araw
₹5,654.35 - ₹5,887.50
Sakop ng taon
₹3,350.00 - ₹6,285.45
Market cap
1.53T INR
Average na Volume
479.63K
P/E ratio
83.10
Dividend yield
0.52%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 23.38B | 22.47% |
Gastos sa pagpapatakbo | 7.52B | 5.17% |
Net na kita | 5.10B | 46.55% |
Net profit margin | 21.81 | 19.64% |
Kita sa bawat share | 19.20 | 46.45% |
EBITDA | 7.15B | 49.58% |
Aktuwal na % ng binabayarang buwis | 29.36% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 36.02B | -0.25% |
Kabuuang asset | 155.86B | 9.12% |
Kabuuang sagutin | 18.69B | 16.38% |
Kabuuang equity | 137.17B | — |
Natitirang share | 265.62M | — |
Presyo para makapag-book | 11.18 | — |
Return on assets | — | — |
Return on capital | 11.30% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 5.10B | 46.55% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients and intermediates, headquartered in Hyderabad. The company manufactures and custom synthesizes generic APIs, intermediates. The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.
In October 2024, Divi and his family were ranked 29th on Forbes list of India’s 100 richest tycoons, with a net worth of $9.2 billion. Wikipedia
Itinatag
Okt 12, 1990
Website
Mga Empleyado
9,741
